Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

22May 2024

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

09May 2024

Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference


Financial Calendar

15May 2024

Bank of America Securities Health Care Conference

Add to Calendar
08May 2024

Amphastar First Quarter Earnings Call

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.